4390-16-3 Usage
Description
Sodium barbiturate is a white to light beige powder that is soluble in water and dilute mineral acid, with a pH of 10.5 for a 1% aqueous solution. It is known to accelerate the propagation of metastatic prostate adenocarcinomas in rats and in tissue culture.
Uses
1. Used in Medical Applications:
Sodium barbiturate is used as a diagnostic agent for the quantification of thrombin in plasma and the estimation of trypsin in duodenal contents. It is also used as a buffer to characterize the functions of two long-chain fatty acid CoA ligase genes (facl) in crude oil-degrading Geobacillus thermodenitrificans NG80-2.
2. Used in Chemical Industry:
Sodium barbiturate is used as a synthetic intermediate and a catalyst in the production of ammonium nitrate propellants and wood impregnating solutions.
Hazard
Toxic by ingestion.
Check Digit Verification of cas no
The CAS Registry Mumber 4390-16-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,9 and 0 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 4390-16:
(6*4)+(5*3)+(4*9)+(3*0)+(2*1)+(1*6)=83
83 % 10 = 3
So 4390-16-3 is a valid CAS Registry Number.
InChI:InChI=1/C4H4N2O3.Na/c7-2-1-3(8)6-4(9)5-2;/h1H2,(H2,5,6,7,8,9);/q;+1
4390-16-3Relevant articles and documents
ANTIMICROBIAL SILVER COMPOSITIONS
-
Page/Page column 63-64, (2010/10/20)
The present invention comprises methods and compositions for antimicrobial silver compositions comprising silver nanoparticles. The present invention further comprises compositions for preparing silver nanoparticles comprising at least one stabilizing agent, one or more silver compounds, at least one reducing agent and a solvent. In one aspect, the stabilizing agent comprises a surfactant or a polymer. The polymer may comprise polymers such as polyacrylamides, polyurethanes, and polyamides. In one aspect, the silver compound comprises a salt comprising a silver cation and an anion. The anion may comprise saccharinate derivatives, long chain fatty acids, and alkyl dicarboxylates. The methods of the present invention comprise treating devices with the silver nanoparticle compositions, including, but not limited to, such devices as woven wound care materials, catheters, patient care devices, and collagen matrices. The present invention further comprises treatment of humans and animals wacr6ith the antimicrobial devices described herein.